# Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients

> **NCT00149994** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 171 (actual)

## Conditions studied

- Liver Transplant

## Interventions

- **DRUG:** Cyclosporine A
- **DRUG:** Tacrolimus
- **DRUG:** Basiliximab
- **DRUG:** Methylprednisolone
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT00149994
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2011-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00149994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00149994, "Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00149994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*